ArticleJournal of hematology & oncology2023

Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.

Huajie Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.